KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Total Current Liabilities (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Total Current Liabilities for 15 consecutive years, with $338.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 15.65% to $338.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $338.2 million, a 15.65% increase, with the full-year FY2025 number at $338.2 million, up 15.65% from a year prior.
  • Total Current Liabilities was $338.2 million for Q4 2025 at Supernus Pharmaceuticals, up from $292.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $735.5 million in Q2 2022 to a low of $240.8 million in Q1 2021.
  • A 5-year average of $412.7 million and a median of $314.6 million in 2024 define the central range for Total Current Liabilities.
  • Biggest YoY gain for Total Current Liabilities was 157.08% in 2023; the steepest drop was 57.82% in 2023.
  • Supernus Pharmaceuticals' Total Current Liabilities stood at $315.4 million in 2021, then surged by 118.14% to $688.0 million in 2022, then tumbled by 57.82% to $290.2 million in 2023, then rose by 0.76% to $292.4 million in 2024, then grew by 15.65% to $338.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Total Current Liabilities are $338.2 million (Q4 2025), $292.4 million (Q4 2024), and $308.7 million (Q2 2024).